Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / vetter pharma to provide fill and finish services to

MLTX - Vetter Pharma to provide fill and finish services to MoonLake Immunotherapeutics

MoonLake Immunotherapeutics
  • MoonLake Immunotherapeutics ( NASDAQ: MLTX ) on Tuesday said it had signed a services agreement with contract development and manufacturing organization Vetter Pharma International GmbH.
  • As per the deal, Vetter will be responsible for fill and finish services.
  • Vetter will oversee the the aseptic filling of syringes with MLTX's investigational nanobody sonelokimab.
  • Vetter will also be responsible for the subsequent assembly into an autoinjector combination device and packaging.
  • MLTX stock -1.8% to $6.93 in morning trading.

For further details see:

Vetter Pharma to provide fill and finish services to MoonLake Immunotherapeutics
Stock Information
Company Name: MoonLake Immunotherapeutics
Stock Symbol: MLTX
Market: NASDAQ
Menu
MLTX MLTX Quote MLTX Short MLTX News MLTX Articles MLTX Message Board
Get MLTX Alerts

News, Short Squeeze, Breakout and More Instantly...